Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
Miller, Timothy ; Cudkowicz, Merit ; Shaw, Pamela J ; Andersen, Peter M ; Atassi, Nazem ; Bucelli, Robert C ; Genge, Angela ; Glass, Jonathan ; Ladha, Shafeeq ; Ludolph, Albert L ; Maragakis, Nicholas J ; McDermott, Christopher J ; Pestronk, Alan ; Ravits, John ; Salachas, François ; Trudell, Randall ; Van Damme, Philip ; Zinman, Lorne ; Bennett, C. Frank ; Lane, Roger ; Sandrock, Alfred ; Runz, Heiko ; Graham, Danielle ; Houshyar, Hani ; McCampbell, Alexander ; Nestorov, Ivan ; Chang, Ih ; McNeill, Manjit ; Fanning, Laura ; Fradette, Stephanie ; Ferguson, Toby A
The New England journal of medicine, 2020-07, Vol.383 (2), p.109-119 [Periódico revisado por pares]United States: Massachusetts Medical Society
Texto completo disponível